Given what we’ve discussed so far in this series, it should not be surprising to see cannabis companies (HMMJ) reporting net losses and negative EPS for the quarter. Once again, we should mention that these losses may not necessarily be bad news for cannabis companies, which incurred expenses that could lead to revenue boosts down the road.
Aurora Cannabis (ACB) is estimated to report a loss per share of 0.07 Canadian dollars, which would be lower than the profit per share of 0.01 Canadian dollars in the corresponding quarter of 2017.
Cronos (CRON) is expected to report a loss per share of 0.02 Canadian dollars, which is flat compared to the corresponding quarter a year ago. Tilray (TLRY) is expected to report a loss per share of 0.13 Canadian dollars for the quarter.
Canopy Growth (WEED) (CGC) is expected to report a loss per share of 0.1 Canadian dollars, which will be down from an income per share of 0.04 Canadian dollars, and CannTrust (CNTTF), which is better than a loss per share of 0.01 Canadian dollars.
HEXO (HEXO), which reported its earnings in October, had a loss per share of 0.05 Canadian dollars and missed analysts’ estimate of a loss per share of 0.02 Canadian dollars. In contrast, Aphria (APHQF) had an income per share of 0.06 Canadian dollars, which beat analysts’ estimate of a loss per share of 0.06 Canadian dollars despite having a loss from core operations.
Stay tuned to our Healthcare sector page for ongoing updates on each of these companies’ earnings this week.